Group One Trading LP Trimmed Cheetah Mobile (CMCM) Position By $309,084; 9 Analysts Covering Merit Medical Systems, Inc. (MMSI)

April 25, 2018 - By Marguerite Chambers

Merit Medical Systems, Inc. (NASDAQ:MMSI) Logo

Group One Trading Lp decreased Cheetah Mobile Inc (CMCM) stake by 83.85% reported in 2017Q4 SEC filing. Group One Trading Lp sold 25,757 shares as Cheetah Mobile Inc (CMCM)’s stock rose 16.78%. The Group One Trading Lp holds 4,960 shares with $60,000 value, down from 30,717 last quarter. Cheetah Mobile Inc now has $1.75B valuation. The stock increased 3.87% or $0.47 during the last trading session, reaching $12.62. About 326,414 shares traded. Cheetah Mobile Inc. (NYSE:CMCM) has risen 11.67% since April 25, 2017 and is uptrending. It has outperformed by 0.12% the S&P500.

Among 9 analysts covering Merit Medical (NASDAQ:MMSI), 9 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Merit Medical had 23 analyst reports since October 23, 2015 according to SRatingsIntel. As per Thursday, July 20, the company rating was initiated by Bank of America. Canaccord Genuity maintained Merit Medical Systems, Inc. (NASDAQ:MMSI) on Thursday, July 27 with “Buy” rating. The firm has “Buy” rating by Canaccord Genuity given on Monday, September 4. The firm has “Buy” rating given on Thursday, March 1 by Canaccord Genuity. On Thursday, November 16 the stock rating was maintained by SunTrust with “Buy”. The company was downgraded on Monday, August 28 by Raymond James. The firm earned “Buy” rating on Thursday, November 30 by Wells Fargo. The company was maintained on Thursday, November 16 by Canaccord Genuity. Craig Hallum maintained the shares of MMSI in report on Thursday, July 27 with “Buy” rating. The rating was upgraded by Barrington Research to “Outperform” on Monday, October 26. See Merit Medical Systems, Inc. (NASDAQ:MMSI) latest ratings:

19/04/2018 Broker: Needham Rating: Buy New Target: $53.0000 Initiate
06/03/2018 Broker: SunTrust Rating: Buy New Target: $55.0 Maintain
28/02/2018 Broker: Piper Jaffray Rating: Buy New Target: $52.0 Maintain
01/03/2018 Broker: Canaccord Genuity Old Rating: Buy New Rating: Buy Old Target: $50 New Target: $57 Maintain
01/03/2018 Broker: Barrington Research Old Rating: Market Perform New Rating: Outperform Upgrade
02/01/2018 Broker: Canaccord Genuity Rating: Buy New Target: $50.0 Maintain
30/11/2017 Broker: Wells Fargo Rating: Buy New Target: $51.0 Maintain
16/11/2017 Broker: SunTrust Rating: Buy New Target: $47.0 Maintain
16/11/2017 Broker: Canaccord Genuity Rating: Buy New Target: $47.5 Maintain
26/10/2017 Broker: Canaccord Genuity Rating: Buy Old Target: $45 New Target: $47.5 Maintain

Among 5 analysts covering Cheetah Mobile Inc (NYSE:CMCM), 1 have Buy rating, 0 Sell and 4 Hold. Therefore 20% are positive. Cheetah Mobile Inc had 9 analyst reports since September 14, 2015 according to SRatingsIntel. The firm earned “Neutral” rating on Friday, May 20 by Macquarie Research. Nomura maintained Cheetah Mobile Inc. (NYSE:CMCM) on Wednesday, August 23 with “Neutral” rating. The company was downgraded on Friday, May 20 by Credit Suisse. Morgan Stanley downgraded Cheetah Mobile Inc. (NYSE:CMCM) on Tuesday, April 26 to “Equal-Weight” rating. The firm has “Overweight” rating by Morgan Stanley given on Thursday, March 17. Credit Suisse downgraded Cheetah Mobile Inc. (NYSE:CMCM) on Wednesday, September 30 to “Neutral” rating.

Group One Trading Lp increased Wendys Co (Call) stake by 64,800 shares to 93,600 valued at $1.54M in 2017Q4. It also upped Ensco Plc (NYSE:ESV) stake by 401,562 shares and now owns 680,833 shares. Ciena Corp (NYSE:CIEN) was raised too.

Since December 15, 2017, it had 0 buys, and 1 sale for $407,782 activity. 9,082 shares were sold by STANGER KENT W, worth $407,782 on Friday, December 15.

Merit Medical Systems, Inc. designs, develops, makes, and markets medical products for interventional and diagnostic procedures worldwide. The company has market cap of $2.27 billion. The companyÂ’s Cardiovascular segment offers cardiology and radiology devices for diagnosing and treating coronary arterial, peripheral vascular, and other non-vascular diseases; and embolotherapeutic products. It has a 81.91 P/E ratio. It also provides vascular access products; guide wires, inflation devices, and diagnostic catheters for use in angiography procedures; therapeutic infusion systems and safety products; drainage catheters and drainage access products, support catheters, vascular retrieval devices, and dialysis access products; and embosphere microspheres and delivery systems, and microcatheters.

Investors sentiment decreased to 1 in Q4 2017. Its down 0.28, from 1.28 in 2017Q3. It worsened, as 29 investors sold Merit Medical Systems, Inc. shares while 69 reduced holdings. 29 funds opened positions while 69 raised stakes. 45.18 million shares or 1.94% more from 44.33 million shares in 2017Q3 were reported. Hanseatic Mgmt Services Incorporated owns 6,523 shares or 0.28% of their US portfolio. Meeder Asset Mngmt holds 0% or 7 shares in its portfolio. Louisiana State Employees Retirement Systems invested in 0.04% or 21,600 shares. The Arizona-based Arizona State Retirement Systems has invested 0.04% in Merit Medical Systems, Inc. (NASDAQ:MMSI). Columbus Circle Invsts has 0.07% invested in Merit Medical Systems, Inc. (NASDAQ:MMSI). New York-based Global X Co Ltd Co has invested 0% in Merit Medical Systems, Inc. (NASDAQ:MMSI). Us State Bank De reported 37,670 shares. Amalgamated Financial Bank has 0.01% invested in Merit Medical Systems, Inc. (NASDAQ:MMSI) for 7,136 shares. Macquarie Gru reported 1.03M shares. Strs Ohio reported 26,900 shares stake. Fisher Asset Mngmt has 0.01% invested in Merit Medical Systems, Inc. (NASDAQ:MMSI). Bancorporation Of America Corp De, a North Carolina-based fund reported 263,116 shares. 10,318 were reported by Piedmont Inv Advsr Limited Company. Argent Cap Ltd Com invested in 95,355 shares or 0.15% of the stock. The Hawaii-based C M Bidwell & Associates Limited has invested 0.24% in Merit Medical Systems, Inc. (NASDAQ:MMSI).

The stock decreased 0.11% or $0.05 during the last trading session, reaching $45.05. About 28,281 shares traded. Merit Medical Systems, Inc. (NASDAQ:MMSI) has risen 52.36% since April 25, 2017 and is uptrending. It has outperformed by 40.81% the S&P500.

Merit Medical Systems, Inc. (NASDAQ:MMSI) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Marguerite Chambers

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: